Septerna (SEPN) Other Non-Current Liabilities (2023 - 2026)
Septerna (SEPN) recorded quarterly Other Non-Current Liabilities of $100000.0 in Q1 2026, up 4900.0% quarter-over-quarter from $2000.0 in Q2 2025, and up 270.37% on a YoY basis from $27000.0 in Q1 2025.
Septerna (SEPN) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Septerna's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 270.37% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $100000.0 (up 270.37% YoY), while the FY2024 annual figure was $33000.0, down 93.96% from the prior year.
- Other Non-Current Liabilities was $100000.0 for Q1 2026 at Septerna, up from $2000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $546000.0 in Q4 2023 to a low of $2000.0 in Q2 2025.
- Historically, Other Non-Current Liabilities has averaged $149833.3 across 4 years, with a median of $66500.0 in 2024.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities sank 93.96% in 2024, then soared 270.37% in 2026.
- A 4-year view of Other Non-Current Liabilities shows it stood at $546000.0 in 2023, then tumbled by 93.96% to $33000.0 in 2024, then sank by 93.94% to $2000.0 in 2025, then surged by 4900.0% to $100000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $100000.0 (Q1 2026), $2000.0 (Q2 2025), and $27000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Sep 30, 2024 | 191,000.00 |
| Dec 31, 2023 | 546,000.00 |